AgbioInvestor Global Ties with ChemRobotics
ChemRobotics and AgbioInvestor are happy to announce the establishment of a new international partnership utilising the pharmacological intelligence platform of ChemRobotics. AgbioInvestor…
ChemRobotics and AgbioInvestor are happy to announce the establishment of a new international partnership utilising the pharmacological intelligence platform of ChemRobotics. AgbioInvestor…
Summary:- TZIELD is the first disease-modifying therapy in T1D, a life-threatening autoimmune disease In a clinical trial, in Stage 2 T1D patients,…
Summary: Approval based on superior survival outcomes of Libtayo plus chemotherapy, compared to chemotherapy alone, in a patient population with a wide…
Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for…